9th International Neoantigen Summit 2026

🌍 Welcome to the 9th International Neoantigen Summit! 🎉
Join industry leaders in Amsterdam for an unparalleled gathering dedicated to the advancements in neoantigen-targeted therapies. With recent breakthroughs such as Moderna's remarkable 49% decrease in disease progression over five years, the momentum in this field is stronger than ever.

This summit serves as the sole dedicated forum for the entire neoantigen development process, featuring topics from validation and identification to clinical readouts, biomarker strategies, and personalized as well as off-the-shelf approaches. Don’t miss your chance to engage with key players and innovators in the industry, including notable names like Nykode Therapeutics, Evaxion, and Geneos.

Here, you will have the opportunity to:

• Access the latest clinical updates! 📈
• Discover breakthrough innovations! 💡
• Form vital partnerships that will propel future neoantigen therapies! 🤝

🗓️ This is your essential annual checkpoint in neoantigen research!

📅 Event Venue:
Park Plaza Victoria Amsterdam
1-5 Damrak, Amsterdam, Noord-Holland
1012 TM, Netherlands

🎟️ Ticket Information:

• Conference + Workshop Day - Drug Developer: EUR 3997.00
• Conference Only - Drug Developer: EUR 2899.00
• Conference + Workshop Day - Academic: EUR 3297.00
• Conference Only - Academic: EUR 2499.00
• Conference + Workshop Day - Service Provider: EUR 4797.00
• Conference Only - Service Provider: EUR 3499.00

🗣️ Featured Speakers Include:

• Ken Carter - Chairman, Black Canyon Bio
• Dirk Hadaschik - Chief Scientific Officer, Cecava
• Fernando Kreutz - Founder and CEO, CellVax Therapeutics
• Jason Barbour - CEO, Echo Immune
• Jon Moore - Chief Scientific Officer, Epitopea Ltd
• And many more esteemed professionals!

🌟 Don’t miss this chance to engage, learn, and innovate in the exciting world of neoantigen therapies!

For further details, view the brochure here.